US Patent Issued to Institute for Research in Biomedicine, Seattle Children's Hospital, Schweizerisches Tropen-und Public Health-Institut on Aug. 12 for "Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to" (American, Malaysian, Swiss, German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,609, issued on Aug. 12, was assigned to Institute for Research in Biomedicine (Bellinzona, Switzerland), Seattle Children's Hospital (Seattle) and Schweizerisches Tropen-und Public Health-Institut (Basel, Switzerland).

"Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to" was invented by Antonio Lanzavecchia (Porza, Switzerland), Joshua Hoong Yu Tan (Shah Alam, Malaysia), Claudia Daubenberger (Mulheim, Germany) and Brandon Wilder (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a fragment of plasmodium circumsporozoite protein according to SEQ ID NO: 1, for ...